144 results
Page 3 of 8
8-K
EX-10.1
bjpyb4920r3v98bggnw
3 Apr 19
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.1
d4cbw00o4lbv db54
25 Jan 19
Titan Pharmaceuticals Announces Reverse Stock Split
12:00am
8-K
EX-10.1
wu8l16nogbspmbi4j
20 Sep 18
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
6:06am
8-K
EX-10..1
diymfoagdro4rlw
3 Aug 18
Titan Announces Amendment to Agreement with Molteni
2:53pm
8-K
EX-10.1
dfaano6eslxd
31 Jul 18
Other Events
3:01pm
8-K
EX-10.1
dt9i ab1shmyge765s
30 May 18
Entry into a Material Definitive Agreement
4:54pm
8-K
EX-10.1
1zd1lvjp82z97cot2xo0
16 May 18
Accomplished Global Pharmaceutical Executive, Federico Seghi Recli, Appointed to Titan’s Board
4:15pm
8-K
EX-10.3
hr5au3c4qx65rojj
26 Mar 18
Titan Executes Agreement for Acquisition by Molteni Ofprobuphine® In Europe and Other Select Territories
12:00am
8-K
EX-10.2
dvmymv8ad
26 Mar 18
Titan Executes Agreement for Acquisition by Molteni Ofprobuphine® In Europe and Other Select Territories
12:00am
8-K
EX-10.1
m2rs3own
26 Mar 18
Titan Executes Agreement for Acquisition by Molteni Ofprobuphine® In Europe and Other Select Territories
12:00am
8-K
EX-10.1
3mpp8hb
7 Feb 18
Titan Announces Amendment to Horizon Loan Agreement
12:00am
8-K
EX-10.1
j32ie8nrfpf
28 Nov 17
Titan Pharmaceuticals Partners with Molteni to Market Probuphine® In Europe
12:00am
8-K
EX-10.23
oui54uspr mc3
28 Jul 17
Titan Pharmaceuticals Secures $10 Million Debt Facility from Horizon Technology Finance
12:00am